Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

NCT03263767 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

47

Enrollment

OTHER

Sponsor class

Stopped Security criteria (MTD)

Conditions

Graft Versus Host Disease

Interventions

DRUG: Fludarabine
DRUG: Clofarabine
RADIATION: Full body irradiation
DRUG: Cyclophosphamide
DRUG: Cyclophosphamide
OTHER: stem cell transplantation
OTHER: nuclear cells
DRUG: Thymoglobulin Injectable Product

Sponsor

Nantes University Hospital